Quest Partners LLC I Teos Therapeutics, Inc. Transaction History
Quest Partners LLC
- $575 Billion
- Q1 2024
A detailed history of Quest Partners LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 1,797 shares of ITOS stock, worth $29,219. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,797
Previous 8,236
78.18%
Holding current value
$29,219
Previous $90.2 Million
72.82%
% of portfolio
0.0%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ITOS
# of Institutions
141Shares Held
30.2MCall Options Held
84.6KPut Options Held
32.2K-
Black Rock Inc. New York, NY4.11MShares$66.9 Million0.0% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$44.5 Million15.24% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2MShares$32.5 Million0.78% of portfolio
-
Boxer Capital, LLC San Diego, CA1.8MShares$29.3 Million1.28% of portfolio
-
Bio Impact Capital LLC Cambridge, MA1.75MShares$28.4 Million3.9% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $578M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...